The efficacy of EMLA ® cream combined with glyceryl trinitrate (GTN) ointment was assessed by a double-blind prospective study. Adult female patients were randomly allocated to receive either EMLA 1 ml or 2 ml combined with GTN 2 mg, or EMLA 2 ml only. The difference in pain scores between the three groups was not statistically significant. When GTN was used with EMLA, the quality of the veins was superior and aided intravenous cannulation. There were no significant side-effects.
zTopical application of a eutectic mixture of local anaesthetic cream (EMLA® Astra Pharmaceuticals) which contains 2.5% lignocaine and 2.5% prilocaine has been shown to reduce pain during venous cannulation [1] [2] [3] . Its disadvantages, however, include expense and vasoconstrictive properties 4 which hinder venous cannulation.
The use of glyceryl trinitrate (GTN) ointment has been used to produce local venodilation and increases the ease of venous cannulation [5] [6] [7] . This has been shown to occur even in the presence of EMLA cream 8, 9 . Pain scores during venous cannulation are similar when either EMLA 2.5 ml or the combination of EMLA 2.5 ml with GTN is used 8 .
The use of EMLA below the recommended dose of 2 to 2.5 ml is less efficacious in reducing pain 10 . In our pilot study we showed that patients pretreated with EMLA 1 ml combined with GTN had similar pain scores during venous cannulation to those receiving EMLA 2 ml. Possibly GTN, due to its venodilation properties, aids in venous cannulation and results in less trauma and pain. GTN may permit a reduction in EMLA dose.
This study was designed to compare the effectiveness of EMLA 2 ml, EMLA 2 ml with GTN and EMLA 1 ml with GTN in reducing pain during venous cannulation and to assess the quality of veins resulting from each treatment.
METHODS
Ethics approval was granted by the Lyell McEwin Health Service Ethics Committee and written informed consent was obtained from the patients. The study was performed in two parts.
Details Relevant to Both Parts
Both parts were prospective double-blind, controlled, randomized trials. Randomization was performed with the use of a computer-generated randomization number table. ASA 1-2 adult female day case patients were studied and all were unpremedicated. Exclusion criteria included past history of difficult venous cannulation, inability to use either hand for intravenous access, or a contraindication to the study medications.
EMLA 5% cream and 2% Nitro-Bid® (glyceryl trinitrate, Fisons Pty Ltd) ointment were used. The doses used were EMLA 2 ml, EMLA 2 ml with GTN 2 mg and EMLA 1 ml with GTN 2 mg (2 mg GTN = 0.1 ml of 2% Nitro-bid ointment).
Pre-filled syringes were used to apply the creams on the dorsum of the hand to cover an area of 3cm x 3 cm. The area used was marked prior to cream application. When GTN was used it was placed first and rubbed on the skin and the EMLA was then applied over the same site. The area was then covered with Tegaderm (3-M). After sixty minutes, the creams were removed. The staff involved in cream application took no further part in the study. Observations were performed within five minutes after the creams were removed. Only one observer (A. M.) was used in the study, who was unaware of which creams were used.
Observations were performed with the patient supine and both arms at the side with venous stasis produced by inflation of a sphygmomanometer cuff to 80 mmHg. In method 1 where both arms were used, both cuffs were simultaneously inflated by connecting the cuffs in series to one sphygmomanometer. No other manoeuvres were performed to aid venous dilation. The veins were assessed visually and by palpation and the quality graded as either small, normal or large. Intravenous access was obtained with a 22 gauge Insyte cannula (Becton Dickinson Inc).
Skin reactions (blanching, erythema), skin temperature (hot/cold) and complications such as headache and hypotension were recorded. Hypotension was defined as a fall in systolic blood pressure of more than 20% of the value prior to cream application. Other observations included age and weight of patient and cream application time. The room temperature throughout the study was 23°C.
Method 1: The aim of this method was to determine the efficacy of GTN in venodilation in the presence of EMLA cream. Patients were studied in a self-controlled trial. The number of patients required was determined by sequential analysis.
Firstly, EMLA 2 ml combined with GTN was compared to EMLA 2 ml alone. EMLA 2 ml alone was placed on the dorsum of one hand and the combination was placed on the other hand. The observer documented which hand had the better quality veins. EMLA 1 ml combined with GTN was then compared with EMLA 2 ml alone in the same manner as stated above.
Method 2: The aim was to determine the efficacy of two doses of EMLA in the presence of GTN. The accuracy of the verbal analog pain score used was compared with the visual analog pain score (VAS).
One hundred and fifty patients were studied in a prospective double-blind randomized trial. Patients were allocated randomly into one of the three treatment groups as stated above. At the time of obtaining written informed consent, the verbal analog pain score was explained to all patients and when the VAS was used this was explained too.
The observer documented venous quality, local reactions and complications. Pain on venous cannulation was graded by all patients with a verbal pain rating (0-10). The last 45 patients also graded the pain on venous cannulation with a VAS scale (0-100 mm). The VAS was performed immediately after the verbal pain score was obtained. The ease of cannulation (difficult, normal, easy) and the number of cannulation attempts were documented.
STATISTICAL METHODS USED
Method 1: The results were analysed with a restricted sequential analysis plan 11 with a two-sided overall significance level of 2α =0.05. A υ (theta) level of 0.8 was used, as a pilot study we performed showed at least 80% incidence in venodilation when GTN was used alone. Previous studies 9 have shown at least 80% incidence of superior veins when GTN was used conconcurrently with EMLA. The sequential plan was designed with a power of 1-β=0.95. With this design a maximum of 40 patients was required. (Figures 1 & 2) .
Method 2: The sample size (n) needed to detect a clinically important difference in verbal pain scores of 1.5 between the three groups with a power of 1-β =0.90 was calculated to be 150. A two-sided significance level 2α=0.05 and a standard deviation of 2 was used in the calculation of the sample size. These calculations were based on results of a pilot study we performed and previously published studies 8, 12 in which a VAS difference of 15 on a 0-100mm scale was considered to be clinically important. All demographic data were analysed with analysis of variance and verbal pain scores analysed with the Kruskal-Wallis test. Chi-squared and Fisher's exact test (where appropriate) were used to analyse the categorical data. The relationship between VAS and verbal pain scores was assessed with Spearman's rank correlation coefficient (ρ).
RESULTS
Method 1: Demographic data is shown in Table 1 . When EMLA 2 ml was compared with EMLA 2 ml combined with GTN, the trial was stopped after nine patients with all preferences in favour of the hand with GTN ( Figure 1 ). When EMLA 2 ml was compared with EMLA 1 ml with GTN, the trial was stopped after twelve patients with eleven patients in favour of the hand with GTN ( Figure 2 ). The only complications were three cases of a mild headache. Despite an incidence of 30% of skin blanching no statistical conclusion could be made due to small numbers.
Method 2: The results of 150 patients were analysed. The demographic data is shown in Table 2 . The three groups were comparable in age, weight and length of time of application of creams.
Pain scores -The statistics for verbal analog pain scores (vps) are given in Table 3 . There was no statistically significant difference between the three groups in respect to vps (P = 0.09). Figure 3 scatter plot illustrates the close agreement between verbal analog pain scores and visual analog pain scores in the last forty-five patients studied. Spearman's rank correlation coefficent ρ (was calculated to be 0.9 with a statistical significance P <0.001.
Venous dilation -Determination of quality of veins, either visually or by palpation, showed a statistical significance (P = 0.001), with a preponderance of patients with larger veins in both GTN groups ( Table 4) .
Ease of cannulation and cannulation attempts -( Table 5 ) -When GTN was used it was shown that cannulation was easier (P = 0.01). There were more patients in the EMLA alone group who required more than one attempt in venous cannulation. This, however, was not statistically significant (P = 0.4).
Skin quality - (Table 6 ) -There was a high incidence of skin blanching when EMLA was used alone (P = 0.001). There was, however, no statistical sig- Values are mean (SD). nificance difference with respect to skin temperature (P = 0.134).
Side-effects -( Table 7 ) -Despite more patients in the GTN groups having headaches, it was not statistically significant (P = 0.5). There was no case of hypotension.
DISCUSSION
Venous cannulation is one of the commonest procedures performed in clinical practice, especially in anaesthesia. Ideally the procedure should be painfree and the vein of adequate size for cannulation to be easy and non-traumatic. The combination of EMLA cream and GTN may be the "ideal" cream for making venous cannulation easy with minimal pain.
EMLA cream has been shown to cause reduction in pain during venous cannulation. [1] [2] [3] 12 Its disadvantages include cost and it appears that EMLA causes local vasoconstriction, thus hindering venous cannulation. It has been shown that veins have a biphasic vasoconstriction-dilation response to EMLA cream 4 . The initial skin blanching appears to be due to vasoconstriction as demonstrated by reflectance spectrophotometry and laser doppler flowmetry. Glyceryl trinitrate relaxes vascular smooth muscle secondary to the production of nitric oxide 13 . When GTN is used topically on its own it causes local venodilation which assists in venous cannulation. [5] [6] [7] 14 This study, like previous studies, has shown that when GTN is used in the presence of EMLA, the GTN promotes venous dilation and therefore cannulation is technically easier 8, 9 . This is illustrated by less blanching, an increased incidence in larger veins and easy cannulations when EMLA is combined with GTN compared with EMLA on its own. This occurs irrespective of the dose of EMLA used. GTN has side-effects including headaches and hypotension. The incidence of these side-effects in this study was low. Previous studies have shown a similar incidence of side-effects. [5] [6] [7] [8] [9] This was not unexpected as the dose of GTN used was well below the dose used in the treatment of angina.
The recommended dose of EMLA cream is 2-2.5 ml and attempts to reduce the dose have failed 10 . This study, however, has shown that the dose of EMLA cream can be reduced to 1 ml when combined with GTN. In this group pain scores were similar to when EMLA 2.5 ml was used. The statistical significance when comparing pain scores in all three groups was 0.09. The power used, however, was 0.9 and a clinically significant difference in verbal pain scores of 1.5 between groups was used to determine the number of patients required in the study. The difference between groups may be tending towards statistical significance. However, it could be argued that a pain score difference of 1.5 is not clinically important. A previous study 8 showed no difference in pain scores. The dose of EMLA used, however, was 2 ml.
A verbal pain score rating was used for comparison with previous studies 8 . The visual analog scale is widely accepted as the most sensitive method for the subjective measurement of pain 15, 16 . In this study there was close agreement with the verbal pain score and visual analog scale. This was also verified in other studies 2 .
GTN combined with EMLA has been used in children with no significant side-effects 9 . Teillol-Foo 9 et al showed that when GTN was used, venous dilation was superior and cannulation easier compared to EMLA alone. A pilot study performed by Teillol-Foo 9 showed that the analgesic effect of EMLA was reduced if it was in contact with GTN. Pain scores, however, were not formally evaluated in the study.
In conclusion, combining EMLA and GTN creates the ideal conditions for venous cannulation in adults. Venous cannulation is technically easier with minimal pain. Also the dose of EMLA may be reduced when combined with GTN, thus increasing the costeffectiveness of EMLA. Further studies are required especially in children.
